Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Hematology|July 1, 1995
Lymphocyte subset reconstitution after allogeneic bone marrow transplantation using radiation-free conditioning regimen for patients with chronic granulocytic leukemiaJ Milosevits, R Dénes, A Poros, et al.
Transplantation Proceedings|December 10, 2013
Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case reportL Wagner, L Lengyel, G Mikala, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Accelerated clearance alone explains ultra-large multimers in von Willebrand disease VicenzaA Gézsi, U Budde, I Deák, et al.
Orvosi Hetilap|October 6, 1996
[The bone-marrow transplantation program in Hungary: report from the period 1990-1995]G Petrányi, T Masszi, L Tímár, et al.
Transplantation Proceedings|February 27, 2016
Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 YearsP Remenyi, G Varga, G Mikala, et al.
Bone Marrow Transplantation|July 7, 2015
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathyK Balassa, H Andrikovics, P Remenyi, et al.
Bone Marrow Transplantation|July 24, 2008
Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach ProgrammeJ Wachowiak, M Labopin, M Miano, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2011
Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease populationA Mohl, Z Boda, R Jager, et al.
Bone Marrow Transplantation|March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USAK W Douglas, A N Parker, P J Hayden, et al.
Blood Cancer Journal|April 22, 2017
Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatmentM A Dimopoulos, A K Stewart, T Masszi, et al.
Pageof 3